Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.59 |
| ▸ | RAB9A | P51151 | 6/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.54 |
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | GAA | P10253 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | CDH1 | P12830 | 1/20 | 0.50 |
| ▸ | APC | P25054 | 1/20 | 0.50 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.50 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | NSD2 | O96028 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5696651 | 0.85 | TDP1 (0.77) | TDP1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL21723107 | 0.85 | TDP1 (0.77) | TDP1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL31017306 | 0.80 | RAB9A (0.73) | TDP1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL4939164 | 0.80 | RAB9A (0.73) | TDP1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL2368284 | 0.78 | TDP1 (0.67) | TDP1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL7907125 | 0.78 | RARB (0.54) | MEN1KMT2AALDH1A1GAAKDM4E | |
| SCHEMBL30092609 | 0.78 | TDP1 (0.67) | TDP1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL2251523 | 0.77 | TDP1 (0.71) | TDP1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL2251936 | 0.77 | TDP1 (0.71) | TDP1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL29337541 | 0.77 | TDP1 (0.65) | TDP1RAB9ASMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11731945-B2 | Redox-active compounds and uses thereof | CMBLU ENERGY AG (DE) | 2023-08-22 | — | — | US | disclosed |
| US-20210253540-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | CMBLU PROJEKT AG (DE) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731945-B2 | Redox-active compounds and uses thereof | NOX4, NQO1, GPX1 | TDP1 1170/4885RAB9A 2185/4885SMN1; SMN2 4506/4885 |
| US-20210253540-A1 | REDOX-ACTIVE COMPOUNDS AND USES THEREOF | NOX4, NQO1, GPX1 | TDP1 1170/4885RAB9A 2185/4885SMN1; SMN2 4506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.